↓ Skip to main content

Dove Medical Press

Article Metrics

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results

Overview of attention for article published in Clinical Ophthalmology, July 2012
Altmetric Badge

Mentioned by

video
1 video uploader

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
18 Mendeley
Title
Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
Published in
Clinical Ophthalmology, July 2012
DOI 10.2147/opth.s30555
Pubmed ID
Authors

Raba Thapa, Nhukesh Maharjan, Govinda Paudyal

Abstract

The purpose of this study was to evaluate the long-term safety, anatomical, and visual outcomes following intravitreal bevacizumab (Avastin; Genentech) on macular edema (ME) secondary to branch retinal vein occlusion (BRVO).

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 6%
Korea, Republic of 1 6%
Unknown 16 89%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 22%
Researcher 4 22%
Professor 2 11%
Student > Bachelor 2 11%
Student > Doctoral Student 2 11%
Other 3 17%
Unknown 1 6%
Readers by discipline Count As %
Medicine and Dentistry 10 56%
Nursing and Health Professions 3 17%
Social Sciences 1 6%
Agricultural and Biological Sciences 1 6%
Unknown 3 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 July 2012.
All research outputs
#11,106,074
of 12,488,808 outputs
Outputs from Clinical Ophthalmology
#1,409
of 1,597 outputs
Outputs of similar age
#120,639
of 144,281 outputs
Outputs of similar age from Clinical Ophthalmology
#23
of 46 outputs
Altmetric has tracked 12,488,808 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,597 research outputs from this source. They receive a mean Attention Score of 3.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 144,281 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.